Litcius/Paper detail

Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?

Hoang Linh Nguyen, Pham Dang Lan, Nguyen Quoc Thai, Daniel A. Nissley, Edward P. O’Brien, Mai Suan Li

2020The Journal of Physical Chemistry B156 citationsDOIOpen Access PDF

Abstract

, 281-292) reported that SARS-CoV-2 exhibits a higher binding affinity, but the difference between the two variants is relatively small. To understand the binding mechnism and experimental results, we investigated how the receptor binding domain (RBD) of SARS-CoV (SARS-CoV-RBD) and SARS-CoV-2 (SARS-CoV-2-RBD) interacts with a human ACE2-PD using molecular modeling. We applied a coarse-grained model to calculate the dissociation constant and found that SARS-CoV-2 displays a 2-fold higher binding affinity. Using steered all-atom molecular dynamics simulations, we demonstrate that, like a coarse-grained simulation, SARS-CoV-2-RBD was associated with ACE2-PD more strongly than was SARS-CoV-RBD, as evidenced by a higher rupture force and larger pulling work. We show that the binding affinity of both viruses to ACE2 is driven by electrostatic interactions.

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicAngiotensin-converting enzyme 2Coronavirus disease 2019 (COVID-19)CoronavirusVirologyDissociation constant2019-20 coronavirus outbreakBiologyChemistryReceptorGeneticsMedicineInfectious disease (medical specialty)OutbreakDiseaseInternal medicineSARS-CoV-2 and COVID-19 ResearchProtein Structure and DynamicsCOVID-19 Clinical Research Studies
Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV? | Litcius